Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Uncategorized Posts

    YouTube / Zoom Meeting: John Gross Presents Updates on Bone and Soft Tissue Tumor Classification

    August 31st, 2020

    To view the video on YouTube, click here

    Read Article

    The Hunt for Predictive Biomarkers to Treat Soft Tissue Sarcomas

    August 29th, 2020

    Schwartz Hunts for Predictive Biomarkers in Soft Tissue Sarcoma

    Gary K. Schwartz, MD, highlights research that is being done with regard to genomic signatures in sarcoma, challenges faced with immunotherapy, and where the field is headed.

    Gary K….

    Read Article

    Another Potential Medication to Treat Chondrosarcoma

    August 16th, 2020

    Targeting the Multidrug Transporter Ptch1 Potentiates Chemotherapy Efficiency

    Abstract

    One of the crucial challenges in the clinical management of cancer is resistance to chemotherapeutics. Multidrug resistance (MDR) has been intensively studied,…

    Read Article

    Literature Review on the Effectiveness of Pazopanib (Votrient)


    Results of a Prospective Phase 2 Study of Pazopanib in Patients With Surgically Unresectable or Metastatic Chondrosarcoma
    Warren Chow, MD1; Paul Frankel, PhD2; Chris Ruel, PhD2; Dejka M. Araujo, MD3; Mohammed Milhem, MBBS4; Scott Okuno, MD5; Lee…

    Read Article

    New Article Posted on the Chondrosarcoma Web Site

    August 12th, 2020

    A new article Treating Chondrosarcoma with Urgency and Compassion has just been posted on the Chondrosarcoma Web Site (www.csfshayna.org). You can find the article on the Commentaries page…

    Read Article

    Meet the Board and Staff of the CS Foundation

    August 10th, 2020

    Please check out our Web Site www.csfshayna.org to get acquainted with our board of directors and staff for the Chondrosarcoma Foundation.

    Read Article

    Research Article of Interest for Patients Considering Immunotherapy in Treating Chondrosarcoma

    July 31st, 2020

    Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas

    MICHAEL J. NATHENSON, ANTHONY P. CONLEY, b EDWARD SAUSVILLE,

    Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA;…

    Read Article

    Honoring the Memory of Those Who Lost Their Battle with Chondrosarcoma


    To honor the memory of those who came before us and on whose shoulders we stand.

    Beloved brother of Angela Saunders Storey, 2 Sep 76 – 19 Jul 20 Sébastien Desjardins, 14 Jul 2020, treasured brother of Stéphanie Shayna Elise Kramer, beloved…

    Read Article

    Medical Literature Review on Diagnostic Biomarkers for Chondrosarcoma

    July 19th, 2020

    EPIGENOMICSVOL. 8, NO. 11SPECIAL REPORT

    Aberrant DNA methylations in chondrosarcoma Pei Liu
    , Jacson K Shen
    , Jianzhong Xu
    , Carol A Trahan
    , Francis J Hornicek
    & Zhenfeng Duan

    Published Online:30 Sep…

    Read Article

    A Medical Literature Review for Treating Conventional Chondrosarcoma


    Here’s a review of current clinical trials for conventional CS (Monga et al, 2020).

    https://www.mdpi.com/2072-6694/12/7/1962/htm

    MDPI.COM

    Non-Conventional Treatments for Conventional Chondrosarcoma

    Abstract: Chondrosarcomas are the most common…

    Read Article